Breaking News Instant updates and real-time market news.

$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

08:25
05/05/20
05/05
08:25
05/05/20
08:25

DJ Utility Average: Pivot points

The following are the pivot points for the DJ Utility Average ($DJU). Pivot High: 777.905, Pivot Low: 759.415. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

TODAY'S FREE FLY STORIES

Periodicals
Bae Systems stock should be on investors' radar, Barron's says » 11:47
05/30/20
05/30
11:47
05/30/20
11:47
BAESY

BAE Systems

$0.00 /

+ (+0.00%)

BAE Systems is one of the…

BAE Systems is one of the few companies to come out of the first quarter unscathed by COVID-19. making the defense contractor a defensive play, Rupert Steiner writes in this week's edition of Barron's. Reference Link

ShowHide Related Items >><<
BAESY BAE Systems
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

05/18/20 UBS
BAE Systems price target lowered to 511 GBp from 700 GBp at UBS
04/29/20 JPMorgan
BAE Systems price target lowered to 765 GBp from 775 GBp at JPMorgan
04/29/20 JPMorgan
BAE Systems shares offer 50% upside potential, says JPMorgan
04/27/20 Morgan Stanley
BAE Systems upgraded to Overweight from Equal Weight at Morgan Stanley
BAESY BAE Systems
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

Periodicals
Cheniere Energy Partners looks like a buy, Barron's says » 11:43
05/30/20
05/30
11:43
05/30/20
11:43
CQP

Cheniere Energy Partners

$33.91 /

+0.87 (+2.63%)

It is rare for an energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CQP Cheniere Energy Partners
$33.91 /

+0.87 (+2.63%)

CQP Cheniere Energy Partners
$33.91 /

+0.87 (+2.63%)

03/24/20 Barclays
Cheniere Energy Partners upgraded to Overweight from Equal Weight at Barclays
03/12/20 Credit Suisse
Cheniere Energy Partners upgraded to Neutral from Underperform at Credit Suisse
03/05/20 UBS
Cheniere Energy Partners upgraded to Buy from Neutral at UBS
02/26/20 Odeon Capital
Cheniere Energy Partners upgraded to Buy from Hold at Odeon Capital
CQP Cheniere Energy Partners
$33.91 /

+0.87 (+2.63%)

CQP Cheniere Energy Partners
$33.91 /

+0.87 (+2.63%)

Periodicals
Marathon among stocks to buy as Americans get back on the road, Barron's says » 10:32
05/30/20
05/30
10:32
05/30/20
10:32
VLO

Valero

$66.62 /

-0.59 (-0.88%)

, MPC

Marathon Petroleum

$35.13 /

-0.08 (-0.23%)

, PSX

Phillips 66

$78.30 /

-0.35 (-0.45%)

Driving is rebounding as…

Driving is rebounding as the economy reopens and Americans take to their cars, viewing them as being more protected spaces than airplanes, trains, or other mass transit, Andrew Bary writes in this week's edition of Barron's. That looks bullish for Marathon Petroleum (MPC) and other big refining stocks, such as Valero Energy (VLO) and Phillips 66 (PSX), that have bounced off their March lows, but are still down an average of 30% this year, the analyst notes. Reference Link

ShowHide Related Items >><<
VLO Valero
$66.62 /

-0.59 (-0.88%)

PSX Phillips 66
$78.30 /

-0.35 (-0.45%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

VLO Valero
$66.62 /

-0.59 (-0.88%)

05/21/20 US Capital Advisors
Valero downgraded to Overweight from Buy at US Capital Advisors
05/13/20 Morgan Stanley
U.S. gasoline consumption appears to have bottomed, says Morgan Stanley
05/04/20 Mizuho
Mizuho upgrades Valero, Phillips 66 and HollyFrontier to Buy from Neutral
05/04/20 Mizuho
Valero upgraded to Buy from Neutral at Mizuho
MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

04/24/20 Citi
Marathon Petroleum downgraded to Neutral from Buy at Citi
03/24/20 Raymond James
Marathon Petroleum double downgraded to Market Perform at Raymond James
03/24/20 Raymond James
Marathon Petroleum downgraded to Market Perform from Strong Buy at Raymond James
PSX Phillips 66
$78.30 /

-0.35 (-0.45%)

05/21/20 US Capital Advisors
Phillips 66 downgraded to Overweight from Buy at US Capital Advisors
05/13/20 Wolfe Research
Phillips 66 downgraded to Peer Perform from Outperform at Wolfe Research
VLO Valero
$66.62 /

-0.59 (-0.88%)

PSX Phillips 66
$78.30 /

-0.35 (-0.45%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

VLO Valero
$66.62 /

-0.59 (-0.88%)

PSX Phillips 66
$78.30 /

-0.35 (-0.45%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

VLO Valero
$66.62 /

-0.59 (-0.88%)

PSX Phillips 66
$78.30 /

-0.35 (-0.45%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

Periodicals
Southwest, Spirit could benefit from pickup in domestic travel, Barron's says » 10:30
05/30/20
05/30
10:30
05/30/20
10:30
DAL

Delta Air Lines

$25.19 /

-0.47 (-1.83%)

, SAVE

Spirit Airlines

$12.96 /

+0.035 (+0.27%)

, LUV

Southwest

$32.11 /

-0.44 (-1.35%)

Airlines have bolstered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
04/21/20 Deutsche Bank
Delta Air Lines price target lowered to $47 from $51 at Deutsche Bank
SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

05/29/20 Wolfe Research
Spirit Airlines downgraded to Underperform from Peer Perform at Wolfe Research
05/18/20 Evercore ISI
Spirit Airlines upgraded to Outperform from In Line at Evercore ISI
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Raymond James
Spirit Airlines downgraded to Market Perform from Outperform at Raymond James
LUV Southwest
$32.11 /

-0.44 (-1.35%)

05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 UBS
Southwest upgraded to Buy from Neutral at UBS
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

Periodicals
Extended Stay could emerge a winner, Barron's says » 10:26
05/30/20
05/30
10:26
05/30/20
10:26
HLT

Hilton

$79.37 /

-1.26 (-1.56%)

, MAR

Marriott

$88.48 /

-3.14 (-3.43%)

, STAY

Extended Stay America

$11.50 /

+0.17 (+1.50%)

The summer travel season…

The summer travel season will look different this year, but that doesn't mean there isn't value to be found among hotel stocks, Carleton English writes in this week's edition of Barron's. Extended Stay America (STAY) shares are down 24% this year-worse than the S&P 500 index, which is off 6%, but better than hotel stocks like Marriott International (MAR) and Hilton Worldwide Holdings (HLT), down 39% and 27%, respectively, the author notes, arguing that Extended Stay stock has room to run. Reference Link

ShowHide Related Items >><<
STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

MAR Marriott
$88.48 /

-3.14 (-3.43%)

HLT Hilton
$79.37 /

-1.26 (-1.56%)

HLT Hilton
$79.37 /

-1.26 (-1.56%)

05/11/20 Raymond James
Hilton price target raised to $82 from $77 at Raymond James
05/08/20 Deutsche Bank
Hilton price target lowered to $74 from $103 at Deutsche Bank
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
04/14/20 Barclays
Investors should start preparing to buy lodging stocks, says Barclays
MAR Marriott
$88.48 /

-3.14 (-3.43%)

05/12/20 BMO Capital
Marriott price target raised to $74 from $65 at BMO Capital
05/12/20 Deutsche Bank
Marriott price target lowered to $88 from $124 at Deutsche Bank
05/12/20 Morgan Stanley
Marriott estimates cut at Morgan Stanley following Q1 report
STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

04/22/20
Fly Intel: Top five analyst upgrades
04/22/20 Jefferies
Jefferies upgrades Extended Stay America to Buy, doubles price target to $14
04/22/20 Jefferies
Extended Stay America upgraded to Buy from Hold at Jefferies
STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

MAR Marriott
$88.48 /

-3.14 (-3.43%)

HLT Hilton
$79.37 /

-1.26 (-1.56%)

STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

MAR Marriott
$88.48 /

-3.14 (-3.43%)

HLT Hilton
$79.37 /

-1.26 (-1.56%)

STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

MAR Marriott
$88.48 /

-3.14 (-3.43%)

HLT Hilton
$79.37 /

-1.26 (-1.56%)

MAR Marriott
$88.48 /

-3.14 (-3.43%)

HLT Hilton
$79.37 /

-1.26 (-1.56%)

Periodicals
Lindblad Expeditions could weather COVID-19 storm, Barron's says » 10:19
05/30/20
05/30
10:19
05/30/20
10:19
LIND

Lindblad Expeditions

$7.87 /

+0.2 (+2.61%)

Lindblad Expeditions may…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

04/28/20 Stifel
Lindblad demand should return faster than 'normal' cruises, says Stifel
04/22/20 Deutsche Bank
Lindblad Expeditions price target lowered to $7 from $16 at Deutsche Bank
04/13/20 Sidoti
Lindblad Expeditions downgraded to Neutral from Buy at Sidoti
03/25/20 Sidoti
Lindblad Expeditions upgraded to Buy from Neutral at Sidoti
LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

Periodicals
Time to buy insurance stocks, Barron's says » 10:15
05/30/20
05/30
10:15
05/30/20
10:15
HIG

Hartford Financial

$38.37 /

-0.205 (-0.53%)

, CB

Chubb

$122.01 /

-1.69 (-1.37%)

Investors tend to dump…

Investors tend to dump insurance stocks at the height of a catastrophe, fearing how large losses will get, but history suggests they should be buying instead, Al Root writes in this week's edition of Barron's. Chubb (CB) and Hartford Financial (HIG) are trading below historical multiples of earnings and book value, and both P&C insurers have strong balance sheets and a history of growth, the author contends. Reference Link

ShowHide Related Items >><<
HIG Hartford Financial
$38.37 /

-0.205 (-0.53%)

CB Chubb
$122.01 /

-1.69 (-1.37%)

HIG Hartford Financial
$38.37 /

-0.205 (-0.53%)

05/05/20 Deutsche Bank
Hartford Financial price target lowered to $53 from $63 at Deutsche Bank
04/14/20 Morgan Stanley
Hartford Financial upgraded to Overweight from Equal Weight at Morgan Stanley
04/08/20 RBC Capital
Hartford Financial price target lowered to $39 from $66 at RBC Capital
04/01/20 Wells Fargo
Hartford Financial upgraded to Overweight from Equal Weight at Wells Fargo
CB Chubb
$122.01 /

-1.69 (-1.37%)

04/24/20 Raymond James
Raymond James downgrades Travelers to Underperform on COVID-19 impact
04/23/20 Wells Fargo
Chubb price target lowered to $142 from $150 at Wells Fargo
04/22/20 MKM Partners
Chubb price target lowered to $145 from $170 at MKM Partners
04/13/20 Deutsche Bank
Chubb upgraded to Hold from Sell at Deutsche Bank
HIG Hartford Financial
$38.37 /

-0.205 (-0.53%)

CB Chubb
$122.01 /

-1.69 (-1.37%)

HIG Hartford Financial
$38.37 /

-0.205 (-0.53%)

HIG Hartford Financial
$38.37 /

-0.205 (-0.53%)

On The Fly
Week in Review: How Trump's policies moved stocks » 10:09
05/30/20
05/30
10:09
05/30/20
10:09
TWTR

Twitter

$30.97 /

-0.63 (-1.99%)

, FB

Facebook

$223.10 /

-2.04 (-0.91%)

, GOOG

Alphabet

$1,430.80 /

+14.43 (+1.02%)

, GOOGL

Alphabet Class A

$1,435.82 /

+17.61 (+1.24%)

, ALK

Alaska Air

$34.19 /

-0.28 (-0.81%)

, AAL

American Airlines

$10.50 /

-0.47 (-4.28%)

, DAL

Delta Air Lines

$25.19 /

-0.47 (-1.83%)

, JBLU

JetBlue

$10.07 /

-0.1 (-0.98%)

, LUV

Southwest

$32.11 /

-0.44 (-1.35%)

, SAVE

Spirit Airlines

$12.96 /

+0.035 (+0.27%)

, UAL

United Airlines

$28.01 /

-0.88 (-3.05%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
UAL United Airlines
$28.01 /

-0.88 (-3.05%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

JBLU JetBlue
$10.07 /

-0.1 (-0.98%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

ALK Alaska Air
$34.19 /

-0.28 (-0.81%)

AAL American Airlines
$10.50 /

-0.47 (-4.28%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

05/29/20 Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
FB Facebook
$223.10 /

-2.04 (-0.91%)

05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

ALK Alaska Air
$34.19 /

-0.28 (-0.81%)

05/29/20 Wolfe Research
Alaska Air upgraded to Outperform from Peer Perform at Wolfe Research
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Alaska Air price target lowered to $35 from $44 at Barclays
04/21/20 Deutsche Bank
Alaska Air price target lowered to $45 from $52 at Deutsche Bank
AAL American Airlines
$10.50 /

-0.47 (-4.28%)

05/04/20 Barclays
American Airlines downgraded to Underweight from Equal Weight at Barclays
05/01/20 Evercore ISI
American Airlines price target lowered to $1 from $10 at Evercore ISI
04/27/20 Citi
American Airlines price target lowered to $10 from $13 at Citi
DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
04/21/20 Deutsche Bank
Delta Air Lines price target lowered to $47 from $51 at Deutsche Bank
JBLU JetBlue
$10.07 /

-0.1 (-0.98%)

05/04/20 Barclays
JetBlue price target lowered to $11 from $16 at Barclays
04/21/20
Fly Intel: Top five analyst downgrades
04/21/20 Susquehanna
JetBlue downgraded to Neutral at Susquehanna
LUV Southwest
$32.11 /

-0.44 (-1.35%)

05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 UBS
Southwest upgraded to Buy from Neutral at UBS
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

05/29/20 Wolfe Research
Spirit Airlines downgraded to Underperform from Peer Perform at Wolfe Research
05/18/20 Evercore ISI
Spirit Airlines upgraded to Outperform from In Line at Evercore ISI
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Raymond James
Spirit Airlines downgraded to Market Perform from Outperform at Raymond James
UAL United Airlines
$28.01 /

-0.88 (-3.05%)

05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/04/20 Barclays
United Airlines price target lowered to $40 from $60 at Barclays
UAL United Airlines
$28.01 /

-0.88 (-3.05%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

JBLU JetBlue
$10.07 /

-0.1 (-0.98%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

ALK Alaska Air
$34.19 /

-0.28 (-0.81%)

AAL American Airlines
$10.50 /

-0.47 (-4.28%)

UAL United Airlines
$28.01 /

-0.88 (-3.05%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

JBLU JetBlue
$10.07 /

-0.1 (-0.98%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

ALK Alaska Air
$34.19 /

-0.28 (-0.81%)

AAL American Airlines
$10.50 /

-0.47 (-4.28%)

UAL United Airlines
$28.01 /

-0.88 (-3.05%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

JBLU JetBlue
$10.07 /

-0.1 (-0.98%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

ALK Alaska Air
$34.19 /

-0.28 (-0.81%)

AAL American Airlines
$10.50 /

-0.47 (-4.28%)

UAL United Airlines
$28.01 /

-0.88 (-3.05%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

JBLU JetBlue
$10.07 /

-0.1 (-0.98%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

ALK Alaska Air
$34.19 /

-0.28 (-0.81%)

AAL American Airlines
$10.50 /

-0.47 (-4.28%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

Periodicals
CareTrust should age well, Barron's says » 09:58
05/30/20
05/30
09:58
05/30/20
09:58
CTRE

CareTrust REIT

$18.62 /

-0.73 (-3.77%)

Stocks of real-estate…

Stocks of real-estate investment trusts focused on senior housing and health have fallen from 15% to 40% in the past three months and some have even had their dividends pared, as COVID-19 took an outsize toll on nursing homes and long-term-care facilities, Avi Salzman writes in this week's edition of Barron's. But it is an essential business, one that will become only more important in the years ahead, the author contends. For investors seeking a company with a manageable amount of debt, one name to consider is CareTrust (CTRE), a REIT that focuses on skilled-nursing facilities, Salzman says. Reference Link

ShowHide Related Items >><<
CTRE CareTrust REIT
$18.62 /

-0.73 (-3.77%)

CTRE CareTrust REIT
$18.62 /

-0.73 (-3.77%)

04/29/20 Raymond James
CareTrust REIT upgraded to Outperform from Market Perform at Raymond James
04/29/20 Raymond James
CareTrust REIT upgraded to Outperform from Market Perform at Raymond James
04/06/20 Mizuho
CareTrust REIT upgraded to Neutral from Underperform at Mizuho
03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
CTRE CareTrust REIT
$18.62 /

-0.73 (-3.77%)

Periodicals
Trump-Twitter feud could mean summer of worry for tech stocks, Barron's says » 09:42
05/30/20
05/30
09:42
05/30/20
09:42
TWTR

Twitter

$30.97 /

-0.63 (-1.99%)

, MSFT

Microsoft

$183.30 /

+2.06 (+1.14%)

, AAPL

Apple

$317.94 /

-0.38 (-0.12%)

, AMZN

Amazon.com

$2,442.37 /

+42.04 (+1.75%)

, GOOGL

Alphabet Class A

$1,435.82 /

+17.61 (+1.24%)

, GOOG

Alphabet

$1,430.80 /

+14.43 (+1.02%)

, FB

Facebook

$223.10 /

-2.04 (-0.91%)

President Trump declared…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$30.97 /

-0.63 (-1.99%)

MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

AAPL Apple
$317.94 /

-0.38 (-0.12%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

05/29/20 Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

05/28/20 Needham
Workday price target raised to $200 from $175 at Needham
05/27/20 Summit Insights
Microsoft initiated with a Buy at Summit Insights
05/18/20 RBC Capital
Microsoft price target raised to $200 from $196 at RBC Capital
05/15/20 Morgan Stanley
Security another large market opportunity for Microsoft, says Morgan Stanley
AAPL Apple
$317.94 /

-0.38 (-0.12%)

05/28/20 JPMorgan
Apple price target raised to $365 from $350 at JPMorgan
05/27/20 BofA
Apple price target raised to $340 from $320 at BofA
05/27/20 Jefferies
Apple price target raised to $370 from $350 at Jefferies
05/27/20 Deutsche Bank
Apple price target raised to $320 from $305 at Deutsche Bank
AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/18/20 Bernstein
Amazon not building standalone overnight network, says Bernstein
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/12/20 Barrington
Amazon interest in AMC 'not outside the realm of possibility,' says Barrington
GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
TWTR Twitter
$30.97 /

-0.63 (-1.99%)

MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

AAPL Apple
$317.94 /

-0.38 (-0.12%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

AAPL Apple
$317.94 /

-0.38 (-0.12%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

AAPL Apple
$317.94 /

-0.38 (-0.12%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

GOOG Alphabet
$1,430.80 /

+14.43 (+1.02%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

AAPL Apple
$317.94 /

-0.38 (-0.12%)

MSFT Microsoft
$183.30 /

+2.06 (+1.14%)

GOOGL Alphabet Class A
$1,435.82 /

+17.61 (+1.24%)

AMZN Amazon.com
$2,442.37 /

+42.04 (+1.75%)

AAPL Apple
$317.94 /

-0.38 (-0.12%)

Periodicals
Delta among travel stocks set for success as lockdowns end, Barron's says » 09:29
05/30/20
05/30
09:29
05/30/20
09:29
SAVE

Spirit Airlines

$12.96 /

+0.035 (+0.27%)

, LUV

Southwest

$32.11 /

-0.44 (-1.35%)

, DAL

Delta Air Lines

$25.19 /

-0.47 (-1.83%)

, STAY

Extended Stay America

$11.50 /

+0.17 (+1.50%)

, LIND

Lindblad Expeditions

$7.87 /

+0.2 (+2.61%)

, MPC

Marathon Petroleum

$35.13 /

-0.08 (-0.23%)

, LVS

Las Vegas Sands

$47.96 /

-0.62 (-1.28%)

Spirit Airlines (SAVE),…

Spirit Airlines (SAVE), Southwest Airlines (LUV), Delta Air Lines (DAL), Extended Stay America (STAY), Lindblad Expeditions Holdings (LIND), Marathon Petroleum (MPC), and Las Vegas Sands (LVS) appear insulated from the worst of the COVID-19 uncertainty and could be lifted over the next year by an emerging revival in travel, Avi Salzman writes in this week's edition of Barron's. Most of these stocks operate in more attractive niches of the industry, from budget airlines to extended-stay hotels, the author adds. Reference Link

ShowHide Related Items >><<
STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

LVS Las Vegas Sands
$47.96 /

-0.62 (-1.28%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

05/29/20 Wolfe Research
Spirit Airlines downgraded to Underperform from Peer Perform at Wolfe Research
05/18/20 Evercore ISI
Spirit Airlines upgraded to Outperform from In Line at Evercore ISI
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Raymond James
Spirit Airlines downgraded to Market Perform from Outperform at Raymond James
LUV Southwest
$32.11 /

-0.44 (-1.35%)

05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 UBS
Southwest upgraded to Buy from Neutral at UBS
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
04/21/20 Deutsche Bank
Delta Air Lines price target lowered to $47 from $51 at Deutsche Bank
STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

04/22/20
Fly Intel: Top five analyst upgrades
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
04/22/20 Jefferies
Jefferies upgrades Extended Stay America to Buy, doubles price target to $14
04/22/20 Jefferies
Extended Stay America upgraded to Buy from Hold at Jefferies
LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

04/28/20 Stifel
Lindblad demand should return faster than 'normal' cruises, says Stifel
04/22/20 Deutsche Bank
Lindblad Expeditions price target lowered to $7 from $16 at Deutsche Bank
04/13/20 Sidoti
Lindblad Expeditions downgraded to Neutral from Buy at Sidoti
03/25/20 Sidoti
Lindblad Expeditions upgraded to Buy from Neutral at Sidoti
MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

05/13/20 Morgan Stanley
U.S. gasoline consumption appears to have bottomed, says Morgan Stanley
04/24/20 Citi
Marathon Petroleum downgraded to Neutral from Buy at Citi
03/24/20 Raymond James
Marathon Petroleum double downgraded to Market Perform at Raymond James
03/24/20 Raymond James
Marathon Petroleum downgraded to Market Perform from Strong Buy at Raymond James
LVS Las Vegas Sands
$47.96 /

-0.62 (-1.28%)

05/21/20
Fly Intel: Top five analyst upgrades
05/21/20 Credit Suisse
Credit Suisse upgrades Las Vegas Sands to Outperform with $58 target
05/21/20 Credit Suisse
Las Vegas Sands assumed with an Outperform from Neutral at Credit Suisse
05/06/20 Roth Capital
Las Vegas Sands price target lowered to $52 from $69 at Roth Capital
STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

LVS Las Vegas Sands
$47.96 /

-0.62 (-1.28%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

LVS Las Vegas Sands
$47.96 /

-0.62 (-1.28%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

LIND Lindblad Expeditions
$7.87 /

+0.2 (+2.61%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

STAY Extended Stay America
$11.50 /

+0.17 (+1.50%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

LVS Las Vegas Sands
$47.96 /

-0.62 (-1.28%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

SAVE Spirit Airlines
$12.96 /

+0.035 (+0.27%)

MPC Marathon Petroleum
$35.13 /

-0.08 (-0.23%)

LVS Las Vegas Sands
$47.96 /

-0.62 (-1.28%)

LUV Southwest
$32.11 /

-0.44 (-1.35%)

DAL Delta Air Lines
$25.19 /

-0.47 (-1.83%)

Conference/Events
American Society of Clinical Oncology (ASCO) to hold virtual meeting » 04:55
05/30/20
05/30
04:55
05/30/20
04:55
ABBV

AbbVie

$92.78 /

+2.77 (+3.08%)

, ALLO

Allogene Therapeutics

$48.08 /

+1.48 (+3.18%)

, AMGN

Amgen

$230.13 /

+6.11 (+2.73%)

, ATNX

Athenex

$10.91 /

-0.21 (-1.89%)

, AVEO

Aveo Pharmaceuticals

$8.14 /

-1.08 (-11.71%)

, AZN

AstraZeneca

$54.60 /

+1.1 (+2.06%)

, BCYC

Bicycle Therapeutics

$17.50 /

-0.785 (-4.29%)

, BLUE

Bluebird Bio

$63.63 /

+2.82 (+4.64%)

, BPMC

Blueprint Medicines

$65.16 /

-1.84 (-2.75%)

, CGEN

Compugen

$15.50 /

+3.13 (+25.30%)

, HALO

Halozyme

$24.26 /

+0.79 (+3.37%)

, EXEL

Exelixis

$24.68 /

+0.35 (+1.44%)

, DCPH

Deciphera

$58.47 /

+1.53 (+2.69%)

, KURA

Kura Oncology

$17.09 /

+0.38 (+2.27%)

, KPTI

Karyopharm

$18.49 /

-0.31 (-1.65%)

, MRK

Merck

$80.85 /

+1.83 (+2.32%)

, BMY

Bristol-Myers

$59.72 /

-0.08 (-0.13%)

, MRSN

Mersana Therapeutics

$22.55 /

+2.85 (+14.47%)

, NXTC

NextCure

$31.20 /

-1.96 (-5.91%)

, PFE

Pfizer

$38.14 /

-0.03 (-0.08%)

, RECN

Changed to RGP

$0.00 /

+ (+0.00%)

, REPL

Replimune Group

$18.85 /

+0.3 (+1.62%)

, SBPH

Spring Bank Pharmaceuticals

$1.66 /

+0.015 (+0.91%)

, SGEN

Seattle Genetics

$157.30 /

+5.53 (+3.64%)

, STML

Stemline

$11.89 /

+ (+0.00%)

, SYRS

Syros Pharmaceuticals

$9.77 /

+0.25 (+2.63%)

, TRIL

Trillium Therapeutics

$6.76 /

+0.995 (+17.26%)

, TROV

Changed name to CRDF

$0.00 /

+ (+0.00%)

, XNCR

Xencor

$30.30 /

-0.69 (-2.23%)

Virtual Annual Meeting of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XNCR Xencor
$30.30 /

-0.69 (-2.23%)

TROV Changed name to CRDF
$0.00 /

+ (+0.00%)

TRIL Trillium Therapeutics
$6.76 /

+0.995 (+17.26%)

SYRS Syros Pharmaceuticals
$9.77 /

+0.25 (+2.63%)

STML Stemline
$11.89 /

+ (+0.00%)

SGEN Seattle Genetics
$157.30 /

+5.53 (+3.64%)

SBPH Spring Bank Pharmaceuticals
$1.66 /

+0.015 (+0.91%)

REPL Replimune Group
$18.85 /

+0.3 (+1.62%)

RECN Changed to RGP
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

NXTC NextCure
$31.20 /

-1.96 (-5.91%)

MRSN Mersana Therapeutics
$22.55 /

+2.85 (+14.47%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

KURA Kura Oncology
$17.09 /

+0.38 (+2.27%)

KPTI Karyopharm
$18.49 /

-0.31 (-1.65%)

HALO Halozyme
$24.26 /

+0.79 (+3.37%)

EXEL Exelixis
$24.68 /

+0.35 (+1.44%)

DCPH Deciphera
$58.47 /

+1.53 (+2.69%)

CGEN Compugen
$15.50 /

+3.13 (+25.30%)

BPMC Blueprint Medicines
$65.16 /

-1.84 (-2.75%)

BMY Bristol-Myers
$59.72 /

-0.08 (-0.13%)

BLUE Bluebird Bio
$63.63 /

+2.82 (+4.64%)

BCYC Bicycle Therapeutics
$17.50 /

-0.785 (-4.29%)

AZN AstraZeneca
$54.60 /

+1.1 (+2.06%)

AVEO Aveo Pharmaceuticals
$8.14 /

-1.08 (-11.71%)

ATNX Athenex
$10.91 /

-0.21 (-1.89%)

AMGN Amgen
$230.13 /

+6.11 (+2.73%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ABBV AbbVie
$92.78 /

+2.77 (+3.08%)

ABBV AbbVie
$92.78 /

+2.77 (+3.08%)

05/22/20 Piper Sandler
Growth of Biohaven's Nurtec continues to beat AbbVie's Ubrelvy, says Piper
05/21/20 Piper Sandler
Piper Sandler remains Overweight on Synlogic after AbbVie ends collaboration
05/18/20 BofA
AbbVie reinstated with a Neutral at BofA
05/12/20 JPMorgan
AbbVie resumed with an Overweight from Neutral at JPMorgan
ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

05/29/20 H.C. Wainwright
Allogene Therapeutics price target raised to $55 from $42 at H.C. Wainwright
05/29/20 Piper Sandler
Allogene Therapeutics price target raised to $70 from $50 at Piper Sandler
05/19/20 Roth Capital
Allogene Therapeutics upgraded to Buy with $60 target at Roth Capital
05/19/20 Roth Capital
Allogene Therapeutics upgraded to Buy from Neutral at Roth Capital
AMGN Amgen
$230.13 /

+6.11 (+2.73%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Cowen
Alexion settlement may yield upside surprise, says Cowen
05/28/20 Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
ATNX Athenex
$10.91 /

-0.21 (-1.89%)

12/13/19 RBC Capital
Athenex oraxol OS and ORR a 'best case,' buy on weakness, says RBC Capital
12/06/19 SunTrust
Athenex initiated with a Buy at SunTrust
11/19/19 RBC Capital
Athenex gets 'third SABCS win' ahead of meeting, says RBC Capital
08/07/19 RBC Capital
Athenex's Oraxol data 'near best-case,' says RBC Capital
AVEO Aveo Pharmaceuticals
$8.14 /

-1.08 (-11.71%)

05/29/20 Piper Sandler
Aveo Pharmaceuticals price target raised to $26 from $18.50 at Piper Sandler
05/29/20 Baird
Aveo Pharmaceuticals price target raised to $24 from $15 at Baird
05/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $10 from $6 at H.C. Wainwright
04/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $6 from $4 at H.C. Wainwright
AZN AstraZeneca
$54.60 /

+1.1 (+2.06%)

05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
BCYC Bicycle Therapeutics
$17.50 /

-0.785 (-4.29%)

04/17/20
Fly Intel: Top five analyst initiations
04/17/20 H.C. Wainwright
Bicycle Therapeutics initiated with a Buy at H.C. Wainwright
04/07/20 Piper Sandler
Bicycle Therapeutics' timelines to be impacted by COVID-19, says Piper Sandler
02/25/20 Piper Sandler
Bicycle Therapeutics price target raised to $30 from $20 at Piper Sandler
BLUE Bluebird Bio
$63.63 /

+2.82 (+4.64%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 RBC Capital
Bluebird Bio initiated with an Outperform at RBC Capital
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
BPMC Blueprint Medicines
$65.16 /

-1.84 (-2.75%)

05/29/20 Raymond James
Blueprint approval for pralsetinib could come before PDUFA, says Raymond James
05/06/20 Nomura Instinet
Deciphera downgraded to Neutral on GIST program risks at Nomura Instinet
05/05/20 Barclays
Blueprint Medicines initiated with an Equal Weight at Barclays
04/29/20 SVB Leerink
Deciphera price target raised to $55 from $50 at SVB Leerink
CGEN Compugen
$15.50 /

+3.13 (+25.30%)

05/26/20 JMP Securities
Compugen resumed with an Outperform at JMP Securities
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 Stifel
Compugen initiated with a Buy at Stifel
05/07/20
Fly Intel: Top five analyst initiations
HALO Halozyme
$24.26 /

+0.79 (+3.37%)

05/26/20 Piper Sandler
Halozyme's Enhanze business nearing accelerated growth, says Piper Sandler
05/12/20 JMP Securities
Halozyme price target raised to $34 from $24 at JMP Securities
05/04/20 Cantor Fitzgerald
Halozyme price target raised to $39 from $35 at Cantor Fitzgerald
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
EXEL Exelixis
$24.68 /

+0.35 (+1.44%)

05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
05/13/20 Piper Sandler
Exelixis mCRPC data for CABOMETYX may accelerate approval, says Piper Sandler
05/06/20 Piper Sandler
Exelixis price target raised to $30 from $23 at Piper Sandler
04/21/20 Guggenheim
Exelixis price target raised to $32 from $27 at Guggenheim
DCPH Deciphera
$58.47 /

+1.53 (+2.69%)

05/18/20 SunTrust
Deciphera price target raised to $91 from $82 at SunTrust
05/18/20 Barclays
Deciphera price target raised to $85 from $80 at Barclays
05/18/20 Piper Sandler
Piper Sandler a buyer of Deciphera shares on the open
05/15/20 Piper Sandler
Deciphera's Ripretinib approved 3 months ahead of schedule, says Piper Sandler
KURA Kura Oncology
$17.09 /

+0.38 (+2.27%)

05/29/20 Piper Sandler
Kura's tipifarnib updates support tumor agnostic potential, says Piper Sandler
05/29/20 H.C. Wainwright
Kura data 'solidifying' confidence in AIM-HN study, says H.C. Wainwright
05/19/20 Deutsche Bank
Kura Oncology price target lowered to $24 from $28 at Deutsche Bank
05/06/20 Wedbush
Kura prioritizing development of tipifarnib for HRAS-HNSCC, says Wedbush
KPTI Karyopharm
$18.49 /

-0.31 (-1.65%)

05/06/20 H.C. Wainwright
Karyopharm price target lowered to $40 from $43 at H.C. Wainwright
04/07/20 Wedbush
Wedbush sees signs of 'potential utility' for Karyopharm's selinexor for COVID
04/07/20 H.C. Wainwright
XPO1 inhibitors have shown promise as COVID-19 treatment, says H.C. Wainwright
03/04/20 Barclays
Karyopharm initiated with an Overweight at Barclays
MRK Merck
$80.85 /

+1.83 (+2.32%)

05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
BMY Bristol-Myers
$59.72 /

-0.08 (-0.13%)

04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
MRSN Mersana Therapeutics
$22.55 /

+2.85 (+14.47%)

05/27/20 H.C. Wainwright
Mersana Therapeutics price target raised to $26 from $13 at H.C. Wainwright
04/29/20 BTIG
Mersana Therapeutics initiated with a Buy at BTIG
01/21/20 H.C. Wainwright
Mersana Therapeutics price target raised to $12 from $7 at H.C. Wainwright
08/20/19 H.C. Wainwright
H.C. Wainwright says trial initiation at higher dosing 'bodes well' for Mersana
NXTC NextCure
$31.20 /

-1.96 (-5.91%)

05/29/20 Piper Sandler
NextCure data shows S15-mediated activity, says Piper Sandler
05/26/20 JMP Securities
NextCure initiated with an Outperform at JMP Securities
04/13/20 Piper Sandler
NextCure could report Phase I biomarker data at ASCO, says Piper Sandler
03/24/20 Benchmark
NextCure initiated with a Buy at Benchmark
PFE Pfizer
$38.14 /

-0.03 (-0.08%)

05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
05/15/20 Goldman Sachs
After Pfizer data, Goldman says Sarepta remains 'leader' in DMD gene therapy
05/15/20 JPMorgan
JPMorgan still sees Sarepta in pole position in DMD space
RECN Changed to RGP
$0.00 /

+ (+0.00%)

01/03/20 Baird
Resources Connection Q3 guidance 'materially below' expectations, says Baird
10/03/19 JPMorgan
Resources Connection near-term outlook remains challenged, says JPMorgan
REPL Replimune Group
$18.85 /

+0.3 (+1.62%)

05/05/20 Barclays
Replimune Group initiated with an Overweight at Barclays
03/25/20 Wedbush
Replimune Group added to Best Ideas List at Wedbush
11/11/19 Roth Capital
Replimune Group price target raised to $30 from $20 at Roth Capital
09/04/19 Roth Capital
Replimune Group initiated with a Buy at Roth Capital
SBPH Spring Bank Pharmaceuticals
$1.66 /

+0.015 (+0.91%)

04/02/20 Piper Sandler
Piper Sandler keeps Neutral on Spring Bank as study enrollment expected to slow
01/29/20 Jefferies
Spring Bank Pharmaceuticals downgraded to Hold from Buy at Jefferies
01/29/20 Piper Sandler
Piper keeps Neutral rating on Spring Bank after inarigivir discontinued
12/30/19
Fly Intel: Top five analyst actions
SGEN Seattle Genetics
$157.30 /

+5.53 (+3.64%)

05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 JMP Securities
Seattle Genetics initiated with an Outperform at JMP Securities
05/26/20 Goldman Sachs
Incyte downgraded to Buy from Conviction Buy at Goldman Sachs
05/26/20 Goldman Sachs
Seattle Genetics upgraded to Conviction Buy from Buy at Goldman Sachs
STML Stemline
$11.89 /

+ (+0.00%)

05/05/20 H.C. Wainwright
Stemline downgraded to Neutral from Buy at H.C. Wainwright
05/05/20 Ladenburg
Stemline downgraded to Neutral from Buy at Ladenburg
05/04/20 Alliance Global Partners
Stemline downgraded to Neutral from Buy at Alliance Global Partners
05/04/20 Wedbush
Stemline downgraded to Neutral from Outperform at Wedbush
SYRS Syros Pharmaceuticals
$9.77 /

+0.25 (+2.63%)

05/29/20 Roth Capital
Syros Pharmaceuticals ASCO update bodes well for ph1 data, says Roth Capital
05/29/20 Piper Sandler
Syros price target raised to $14 after ASCO update at Piper Sandler
04/23/20 JonesTrading
Syros Pharmaceuticals initiated with a Buy at JonesTrading
03/06/20 H.C. Wainwright
Syros Pharmaceuticals price target lowered to $8 from $10 at H.C. Wainwright
TRIL Trillium Therapeutics
$6.76 /

+0.995 (+17.26%)

05/26/20 JMP Securities
Trillium Therapeutics initiated with an Outperform at JMP Securities
08/19/19
Fly Intel: Top five analyst downgrades
08/19/19 H.C. Wainwright
Trillium Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TROV Changed name to CRDF
$0.00 /

+ (+0.00%)

01/28/20 Noble Capital
Trovagene resumed with an Outperform at Noble Capital
XNCR Xencor
$30.30 /

-0.69 (-2.23%)

05/13/20 Piper Sandler
Xencor's XmAb20717 shows first-ever clinical benefit, says Piper Sandler
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Barclays
Xencor initiated with an Underweight at Barclays
02/25/20 Guggenheim
Xencor upgraded to Buy from Neutral at Guggenheim
XNCR Xencor
$30.30 /

-0.69 (-2.23%)

TRIL Trillium Therapeutics
$6.76 /

+0.995 (+17.26%)

SYRS Syros Pharmaceuticals
$9.77 /

+0.25 (+2.63%)

STML Stemline
$11.89 /

+ (+0.00%)

SGEN Seattle Genetics
$157.30 /

+5.53 (+3.64%)

SBPH Spring Bank Pharmaceuticals
$1.66 /

+0.015 (+0.91%)

REPL Replimune Group
$18.85 /

+0.3 (+1.62%)

RECN Changed to RGP
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

NXTC NextCure
$31.20 /

-1.96 (-5.91%)

MRSN Mersana Therapeutics
$22.55 /

+2.85 (+14.47%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

KURA Kura Oncology
$17.09 /

+0.38 (+2.27%)

KPTI Karyopharm
$18.49 /

-0.31 (-1.65%)

HALO Halozyme
$24.26 /

+0.79 (+3.37%)

EXEL Exelixis
$24.68 /

+0.35 (+1.44%)

DCPH Deciphera
$58.47 /

+1.53 (+2.69%)

CGEN Compugen
$15.50 /

+3.13 (+25.30%)

BPMC Blueprint Medicines
$65.16 /

-1.84 (-2.75%)

BMY Bristol-Myers
$59.72 /

-0.08 (-0.13%)

BLUE Bluebird Bio
$63.63 /

+2.82 (+4.64%)

BCYC Bicycle Therapeutics
$17.50 /

-0.785 (-4.29%)

AZN AstraZeneca
$54.60 /

+1.1 (+2.06%)

AVEO Aveo Pharmaceuticals
$8.14 /

-1.08 (-11.71%)

ATNX Athenex
$10.91 /

-0.21 (-1.89%)

AMGN Amgen
$230.13 /

+6.11 (+2.73%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ABBV AbbVie
$92.78 /

+2.77 (+3.08%)

  • 29
    May
TRIL Trillium Therapeutics
$6.76 /

+0.995 (+17.26%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

BMY Bristol-Myers
$59.72 /

-0.08 (-0.13%)

AZN AstraZeneca
$54.60 /

+1.1 (+2.06%)

AMGN Amgen
$230.13 /

+6.11 (+2.73%)

ABBV AbbVie
$92.78 /

+2.77 (+3.08%)

XNCR Xencor
$30.30 /

-0.69 (-2.23%)

STML Stemline
$11.89 /

+ (+0.00%)

SGEN Seattle Genetics
$157.30 /

+5.53 (+3.64%)

SBPH Spring Bank Pharmaceuticals
$1.66 /

+0.015 (+0.91%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

MRSN Mersana Therapeutics
$22.55 /

+2.85 (+14.47%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

KPTI Karyopharm
$18.49 /

-0.31 (-1.65%)

HALO Halozyme
$24.26 /

+0.79 (+3.37%)

EXEL Exelixis
$24.68 /

+0.35 (+1.44%)

DCPH Deciphera
$58.47 /

+1.53 (+2.69%)

BPMC Blueprint Medicines
$65.16 /

-1.84 (-2.75%)

BMY Bristol-Myers
$59.72 /

-0.08 (-0.13%)

BLUE Bluebird Bio
$63.63 /

+2.82 (+4.64%)

BCYC Bicycle Therapeutics
$17.50 /

-0.785 (-4.29%)

AZN AstraZeneca
$54.60 /

+1.1 (+2.06%)

AVEO Aveo Pharmaceuticals
$8.14 /

-1.08 (-11.71%)

ATNX Athenex
$10.91 /

-0.21 (-1.89%)

AMGN Amgen
$230.13 /

+6.11 (+2.73%)

ALLO Allogene Therapeutics
$48.08 /

+1.48 (+3.18%)

ABBV AbbVie
$92.78 /

+2.77 (+3.08%)

TRIL Trillium Therapeutics
$6.76 /

+0.995 (+17.26%)

RECN Changed to RGP
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.14 /

-0.03 (-0.08%)

MRSN Mersana Therapeutics
$22.55 /

+2.85 (+14.47%)

MRK Merck
$80.85 /

+1.83 (+2.32%)

EXEL Exelixis
$24.68 /

+0.35 (+1.44%)

BMY Bristol-Myers
$59.72 /

-0.08 (-0.13%)

AZN AstraZeneca
$54.60 /

+1.1 (+2.06%)

ABBV AbbVie
$92.78 /

+2.77 (+3.08%)

Hot Stocks
Humana awarded Medicaid contract from Kentucky CHFS » 18:26
05/29/20
05/29
18:26
05/29/20
18:26
HUM

Humana

$411.26 /

+7.275 (+1.80%)

Humana has been selected…

Humana has been selected by the Kentucky Cabinet for Health and Family Services to continue serving children and adults across the health company's home state of Kentucky through the Department for Medicaid Services. Humana currently provides coordinated medical, wellness, and pharmacy benefits coverage and services to 150,000 Kentucky Medicaid recipients. The new contract supports the company continuing its longstanding community presence, strong provider partnerships, and unique commitment to population health. "The decision by the Commonwealth of Kentucky means a great deal to all of us at Humana. As a company with deep roots in the Commonwealth and a team of 12,000 employees in Kentucky, our commitment to serve our members and improve health across Kentucky is unyielding," said Jeb Duke, Humana's Kentucky-based Medicaid leader. "We were born in the Bluegrass nearly 60 years ago, and we've been fortunate through the years to be able to help our families, friends and neighbors live healthier lives. We commend the state for moving forward with enhancements to Medicaid that will better support people receiving coverage through the program." Under the terms of Kentucky CHFS's agreement, the renewed Medicaid program will begin enrolling eligible Kentuckians in January 2021. The statewide program will provide health care to approximately 1.26 million Medicaid enrollees. The statewide contract term is set to last through 2024, with the potential for an additional six two-year contract extensions.

ShowHide Related Items >><<
HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

Hot Stocks
Zscaler CEO: Companies built for the cloud will be winners » 18:24
05/29/20
05/29
18:24
05/29/20
18:24
ZS

Zscaler

$98.09 /

+22.21 (+29.27%)

In an interview on…

In an interview on CNBC's Mad Money, Jay Chaudhry said the biggest thing COVID-19 has done is accelerate digital transformation. He said Zscaler is well positioned to capitalize on the work from home trend that has resulted from the pandemic.

ShowHide Related Items >><<
ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

05/29/20 Baird
Zscaler price target raised to $100 from $80 at Baird
05/29/20 Rosenblatt
Zscaler price target raised to $115 from $75 at Rosenblatt
05/29/20 DA Davidson
Zscaler price target raised to $105 from $65 at DA Davidson
05/29/20 Cowen
Zscaler price target raised to $100 from $80 at Cowen
ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

Hot Stocks
Lufthansa board accepts commitments offered by Germany to EU » 18:11
05/29/20
05/29
18:11
05/29/20
18:11
DLAKY

Lufthansa

$0.00 /

+ (+0.00%)

The Lufthansa Executive…

The Lufthansa Executive Board has decided to accept the commitments offered by Germany to the EU Commission for the stabilization package negotiated with the Economic Stabilization Fund of the Federal Republic of Germany. The scope of the conditions required in the EU Commission's view has been reduced in comparison with initial indications. Lufthansa will therefore be obliged to transfer to one competitor each at the Frankfurt and Munich airports up to 24 take-off and landing rights, i.e. three take-off and three landing rights per aircraft and day, for the stationing of up to four aircraft. For one and a half years, this option is only available to new competitors at the Frankfurt and Munich airports. If no new competitor makes use of this option, it will be extended to existing competitors at the respective airports. The slots will be allocated in a bidding process. The slots can only be taken over by a European competitor that has not itself received any substantial state recapitalization as a result of the corona pandemic. The Supervisory Board must approve the stabilization package negotiated with the WSF, including the commitments to the EU Commission. Subsequent to the Supervisory Board's decision, the company intends to convene an Extraordinary General Meeting in the near future to obtain shareholder approval for the WSF stabilization measures.

ShowHide Related Items >><<
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

05/29/20 Citi
Citi opens 'positive catalyst watch' on Sell-rated Lufthansa
05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/06/20 HSBC
Lufthansa downgraded to Reduce from Hold at HSBC
04/24/20 Barclays
Lufthansa price target lowered to EUR 6.20 from EUR 12.70 at Barclays
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

Hot Stocks
SPDR Gold Shares holdings rise to 1,123.14MT from 1,119.63MT » 17:59
05/29/20
05/29
17:59
05/29/20
17:59
GLD

SPDR Gold Shares

$162.90 /

+1.17 (+0.72%)

This is the third…

This is the third consecutive increase and the highest level of holdings since April of 2013.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

Hot Stocks
Evolent Health: Passport Health not chosen for Kentucky MCO contract » 17:40
05/29/20
05/29
17:40
05/29/20
17:40
EVH

Evolent Health

$8.89 /

-0.17 (-1.88%)

Evolent Health announced…

Evolent Health announced that its partner, Passport Health Plan, received notification from the Kentucky Cabinet for Health and Family Services that Passport has not been awarded a Kentucky Managed Care Organization contract for the next contract period, which commences January 1, 2021. Evolent will support Passport in protesting this decision. Evolent will continue to provide services to Passport until the new Medicaid contracts take effect on January 1, 2021.

ShowHide Related Items >><<
EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

03/26/20 Cowen
Cowen sees three healthcare IT names poised for rebound
02/26/20 Cantor Fitzgerald
Evolent Health price target lowered to $14 from $16 at Cantor Fitzgerald
02/26/20 Piper Sandler
Evolent Health price target raised to $17 from $10.15 at Piper Sandler
01/23/20 Cantor Fitzgerald
Evolent Health price target raised to $16 from $10 at Cantor Fitzgerald
EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

Periodicals
Germany, EU reach pact on Lufthansa bailout, Bloomberg says » 17:36
05/29/20
05/29
17:36
05/29/20
17:36
DLAKY

Lufthansa

$0.00 /

+ (+0.00%)

Germany has struck an…

Germany has struck an agreement with the European Commission on Lufthansa's landing slots at hub airports, which could clear the path for the company's approval of Germany's $9.9B bailout offer, Bloomberg's Arne Delfs and William Wilkes report, citing a government official. Following days of talks, the EU and German government agreed that the carrier will cut the number of planes it kept at Frankfurt and Munich airports and let rival airlines take up flight slots, the authors note. Reference Link

ShowHide Related Items >><<
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

05/29/20 Citi
Citi opens 'positive catalyst watch' on Sell-rated Lufthansa
05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/06/20 HSBC
Lufthansa downgraded to Reduce from Hold at HSBC
04/24/20 Barclays
Lufthansa price target lowered to EUR 6.20 from EUR 12.70 at Barclays
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

Hot Stocks
PDL Community Bancorp authorizes buyback for up to 5% of outstanding stock » 17:29
05/29/20
05/29
17:29
05/29/20
17:29
PDLB

PDL Community Bancorp

$8.96 /

-0.02 (-0.22%)

PDL Community Bancorp…

PDL Community Bancorp announced that its board has adopted a share repurchase program intended to enhance shareholder value effective June 1, 2020. Under the repurchase program, the company may repurchase up to 864,987 shares of its common stock, or approximately 5% of the current outstanding shares.

ShowHide Related Items >><<
PDLB PDL Community Bancorp
$8.96 /

-0.02 (-0.22%)

Syndicate
Diffusion Pharmaceuticals files to sell 5.82M shares of common stock for holders  17:22
05/29/20
05/29
17:22
05/29/20
17:22
DFFN

Diffusion Pharmaceuticals

$1.30 /

+0.01 (+0.78%)

 
ShowHide Related Items >><<
DFFN Diffusion Pharmaceuticals
$1.30 /

+0.01 (+0.78%)

DFFN Diffusion Pharmaceuticals
$1.30 /

+0.01 (+0.78%)

12/18/19 H.C. Wainwright
Diffusion price target lowered to $3.50 from $10 at H.C. Wainwright
Hot Stocks
General Dynamics awarded $3.42B Army contract for Hydra-70 rocket systems » 17:21
05/29/20
05/29
17:21
05/29/20
17:21
GD

General Dynamics

$146.85 /

-1.675 (-1.13%)

General Dynamics was…

General Dynamics was awarded a $3.42B hybrid contract for production and engineering services for Hydra-70 rocket systems. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of September 30, 2026. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

05/20/20 RBC Capital
RBC Capital starts General Dynamics at Outperform on sub 'dominance'
05/20/20 RBC Capital
General Dynamics initiated with an Outperform at RBC Capital
05/19/20 Seaport Global
Seaport Global starts 'underappreciated' General Dynamics at Buy
05/19/20 Seaport Global
General Dynamics initiated with a Buy at Seaport Global
GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

Syndicate
CHF Solutions files to sell 1.8M shares of common stock for holders  17:08
05/29/20
05/29
17:08
05/29/20
17:08
CHFS

CHF Solutions

$0.38 /

-0.0029 (-0.77%)

 
ShowHide Related Items >><<
CHFS CHF Solutions
$0.38 /

-0.0029 (-0.77%)

CHFS CHF Solutions
$0.38 /

-0.0029 (-0.77%)

General news
Treasury Market Summary » 17:05
05/29/20
05/29
17:05
05/29/20
17:05

Treasury Market Summary:…

Treasury Market Summary: t was mostly a waiting game for the markets on Friday as May came to an end. The focus on two events today, the press conference from President Trump, and the comments from Fed Chair Powell. But neither really said anything new or surprising. Jitters over U.S.-China relations and fears the President could outline harsh sanctions saw risk appetite fade ahead of his comments with the Dow and S&amp;P 500 sliding just over 1%. But there was a big sigh of relief as he refrained from imposing any harsh economic or financial measures, while stating what had been indicated Wednesday by Secretary of State Pompeo that the U.S. would be ending its special treatment of Hong Kong. The President also didn't mention tariffs or ending the phase one trade deal. The NASDAQ closed with a solid 1.29% gain, while the S&amp;P 500 was up 0.48%. The Dow closed 0.07% lower. Treasuries rallied into the finish, led by the long end amid a record June 1 duration extension index, and still reflecting some haven demand after historically weak spending and export data. Chair Powell merely reiterated the FOMC was not looking to shift to a negative rate stance, while there was no mention of yield curve controls. View the summary.

Syndicate
Athersys files to sell 35M shares of common stock  17:04
05/29/20
05/29
17:04
05/29/20
17:04
ATHX

Athersys

$2.89 /

+0.11 (+3.96%)

 
ShowHide Related Items >><<
ATHX Athersys
$2.89 /

+0.11 (+3.96%)

ATHX Athersys
$2.89 /

+0.11 (+3.96%)

04/23/20 SMBC Nikko
Athersys initiated with an Outperform at SMBC Nikko
08/26/19 Dawson James
Athersys initiated with a Buy at Dawson James
ATHX Athersys
$2.89 /

+0.11 (+3.96%)

ATHX Athersys
$2.89 /

+0.11 (+3.96%)

Hot Stocks
GSE Systems will not timely file Annual Report by extended due date of May 29 » 17:02
05/29/20
05/29
17:02
05/29/20
17:02
GVP

GSE Systems

$1.05 /

+0.02 (+1.94%)

GSE Systems announced…

GSE Systems announced that, due to circumstances primarily stemming from the COVID-19 pandemic, the company will not timely file its Annual Report on Form 10-K for the year ended December 31, 2019 by the extended due date of May 29. The company continues to work diligently with its auditors to complete its annual filing with the U.S. SEC as soon as reasonably practical and is targeting submission of this filing by June 15.

ShowHide Related Items >><<
GVP GSE Systems
$1.05 /

+0.02 (+1.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.